← All organizations

ImmuneOncia Therapeutics Inc.

For profitWebsite ↗

Also known as: ImmuneOncia Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2024

Timeline

2010s

Jun 1, 2016
ImmuneOncia Therapeutics Inc.— Founded

Drugs by trial phase (2 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

imc001

Phase 1 (1 own, 0 via acquisition)

imc-002

Indications

Studied for

Recent trials (9)

NCT06365840Lead sponsorPhase 2Jun 30, 2024
NCT05276310Study directorPhase 1May 10, 2022
NCT05276310Lead sponsorPhase 1May 10, 2022
NCT04414163Study directorPhase 2Jun 30, 2020
NCT04414163Lead sponsorPhase 2Jun 30, 2020
NCT04306224Study directorPhase 1May 31, 2020
NCT04306224Lead sponsorPhase 1May 31, 2020
NCT03644056Study directorPhase 1Mar 22, 2018
NCT03644056Lead sponsorPhase 1Mar 22, 2018

Details

Founded: Seongnam, KR Jun 1, 2016
Last known activity: Jun 30, 2024